Literature DB >> 3264447

Biochemical evidence of disturbed bone metabolism and calcium homeostasis in two types of autosomal dominant osteopetrosis.

J Bollerslev1, H K Nielsen, H F Larsen, L Mosekilde.   

Abstract

Biochemical markers of bone resorption and bone formation were measured in 14 patients with autosomal dominant osteopetrosis, and compared with age- and sex-matched controls. There were eight patients with the radiological type I characterized by diffuse, symmetrical osteosclerosis with pronounced sclerosis of the skull and enlarged thickness of the cranial vault, and six patients with type II characterized by diffuse, symmetrical osteosclerosis, "Rugger-Jersey spine" and "endobones" (bone within a bone) in the pelvis. Serum levels of alkaline phosphatase and osteocalcin in types I and II did not differ from controls indicating normal bone formation. However, a significantly decreased fasting renal excretion of phosphate and hydroxyproline in both types compared with normal controls, suggests a reduced bone resorption. Serum levels of parathyroid hormone (PTH), albumin-corrected calcium, phosphate, and acid phosphatase were normal in type I. In type II serum levels of albumin-corrected calcium and PTH were significantly increased (p less than 0.05 and p less than 0.01). The level of acid phosphatase was markedly increased in this type (p less than 0.01). These findings suggest differences between the two types in calcium homeostasis and bone metabolism, and thus corroborate the evidence that the two radiological types reflect two different disorders of bone resorption.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3264447     DOI: 10.1111/j.0954-6820.1988.tb19614.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  7 in total

1.  Autosomal dominant osteopetrosis: report of a Norwegian family with radiographic or anamnestic findings differing from the generally accepted classification.

Authors:  N Lund-Sørensen; T E Gudmundsen; H Ostensen
Journal:  Skeletal Radiol       Date:  1997-03       Impact factor: 2.199

2.  Osteoclasts from patients with autosomal dominant osteopetrosis type I caused by a T253I mutation in low-density lipoprotein receptor-related protein 5 are normal in vitro, but have decreased resorption capacity in vivo.

Authors:  Kim Henriksen; Jeppe Gram; Pernille Høegh-Andersen; Rune Jemtland; Thor Ueland; Morten H Dziegiel; Sophie Schaller; Jens Bollerslev; Morten A Karsdal
Journal:  Am J Pathol       Date:  2005-11       Impact factor: 4.307

3.  Characterization of osteoclasts from patients harboring a G215R mutation in ClC-7 causing autosomal dominant osteopetrosis type II.

Authors:  Kim Henriksen; Jeppe Gram; Sophie Schaller; Bjarne H Dahl; Morten H Dziegiel; Jens Bollerslev; Morten A Karsdal
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

4.  Generation of the first autosomal dominant osteopetrosis type II (ADO2) disease models.

Authors:  Imranul Alam; Amie K Gray; Kang Chu; Shoji Ichikawa; Khalid S Mohammad; Marta Capannolo; Mattia Capulli; Antonio Maurizi; Maurizio Muraca; Anna Teti; Michael J Econs; Andrea Del Fattore
Journal:  Bone       Date:  2013-11-01       Impact factor: 4.398

Review 5.  Friend or foe: high bone mineral density on routine bone density scanning, a review of causes and management.

Authors:  Celia L Gregson; Sarah A Hardcastle; Cyrus Cooper; Jonathan H Tobias
Journal:  Rheumatology (Oxford)       Date:  2013-02-27       Impact factor: 7.580

6.  Mutations in Known Monogenic High Bone Mass Loci Only Explain a Small Proportion of High Bone Mass Cases.

Authors:  Celia L Gregson; Lawrie Wheeler; Sarah A Hardcastle; Louise H Appleton; Kathryn A Addison; Marieke Brugmans; Graeme R Clark; Kate A Ward; Margaret Paggiosi; Mike Stone; Joegi Thomas; Rohan Agarwal; Kenneth E S Poole; Eugene McCloskey; William D Fraser; Eleanor Williams; Alex N Bullock; George Davey Smith; Matthew A Brown; Jon H Tobias; Emma L Duncan
Journal:  J Bone Miner Res       Date:  2015-10-06       Impact factor: 6.741

Review 7.  The Genetic Architecture of High Bone Mass.

Authors:  Celia L Gregson; Emma L Duncan
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-29       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.